CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event.

Chiva-Blanch, Gemma; Suades Soler, Rosa, 1984-; Crespo, Javier; Vilahur, Gemma; Arderiu, Gemma; Padró, Teresa; Corella, Dolores; Salas-Salvadó, Jordi; Arós, Fernando; Martínez-González, Miguel Ángel, 1957-; Ros, Emilio; Fitó Colomer, Montserrat; Estruch, Ramón; Badimón, Lina, 1953-

Home
→
Recerca: articles, congressos, llibres
→
Hospital del Mar Research Institute
→
Articles (Hospital del Mar Research Institute)
→
View Item

dc.contributor.author	Chiva-Blanch, Gemma
dc.contributor.author	Suades Soler, Rosa, 1984-
dc.contributor.author	Crespo, Javier
dc.contributor.author	Vilahur, Gemma
dc.contributor.author	Arderiu, Gemma
dc.contributor.author	Padró, Teresa
dc.contributor.author	Corella, Dolores
dc.contributor.author	Salas-Salvadó, Jordi
dc.contributor.author	Arós, Fernando
dc.contributor.author	Martínez-González, Miguel Ángel, 1957-
dc.contributor.author	Ros, Emilio
dc.contributor.author	Fitó Colomer, Montserrat
dc.contributor.author	Estruch, Ramón
dc.contributor.author	Badimón, Lina, 1953-
dc.date.accessioned	2016-07-19T09:47:33Z
dc.date.issued	2016
dc.identifier.citation	Chiva-Blanch G, Suades R, Crespo J, Vilahur G, Arderiu G, Padró T. et al. CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. Int J Cardiol. 2016 Apr 1;208:147-9. doi: 10.1016/j.ijcard.2016.01.211
dc.identifier.issn	0167-5273
dc.identifier.uri	http://hdl.handle.net/10230/27086
dc.description.abstract	Circulating microparticles (cMPs) are phospholipid-rich blebs of 0.1–1.0 μm in size shed from the plasma membrane of eukaryotic cells when injured, activated, or undergoing apoptosis. MPs have been shown to reflect cellular activation and/or tissue degeneration occurring in vivo.
dc.description.sponsorship	GC-B is a Sara Borrell Postdoctoral Fellow (CD13/00023) from Instituto de Salud Carlos III. This work has been possible thanks to funding received from Spanish Ministry of Economy and Competitiveness (Plan Estatal de I + D + I 2013–2016, SAF2013-42962-R, to LB), from the Cardiovascular Research Network of Instituto de Salud Carlos III (RIC, RD12/0042/0027 to LB; SAF2012-40208 to GV) and from CIBER CB06/03 Fisiopatología de la Obesidad y la Nutrición of Instituto de Salud Carlos III, (CIBERobn, RD06/0045 to RE). JS-S and RE thank the Fundació la Marató TV3. CIBEROBN is an initiative of ISCIII, Spain.
dc.format.mimetype	application/pdf
dc.language.iso	cat
dc.publisher	Elsevier
dc.relation.ispartof	International Journal of Cardiology. 2016 Apr 1;208:147-9
dc.rights	© Elsevier. http://dx.doi.org/10.1016/j.ijcard.2016.01.211
dc.subject.other	Sistema cardiovascular -- Malalties
dc.subject.other	Limfòcits
dc.title	CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event.
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	http://dx.doi.org/10.1016/j.ijcard.2016.01.211
dc.rights.accessRights	info:eu-repo/semantics/openAccess
dc.type.version	info:eu-repo/semantics/acceptedVersion